Foster Mom Accused Of Seeking Unwanted Surgeries For Child Adopted From Zambia ibtimes.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ibtimes.com.au Daily Mail and Mail on Sunday newspapers.
Renton mother charged in âmedical child abuseâ case against adopted 6-year-old daughter
By Olivia LaVoice and Q13 News Staff
Published article
RENTON, Wash. - Charges have been filed against a Renton mother under investigation for medical child abuse, a case in which prosecutors say is something they haven t seen in recent memory.
The investigation into 31-year-old Sophie Hartman began with a series of doctors who believed her now 6-year-old adopted daughter was being given unnecessary medical treatment at the urging of her mother.
Court documents say the child has had nearly 500 medical appointments since she was around 2 years old and has had what doctors called an unnecessary medical procedure, with a surgically implanted feeding tube, as well as a cecostomy tube, to help flush the intestines. The child also had leg braces and a wheelchair despite doctors telling her mother that they were unnecessary, according to court documents.
May 21, 2021
Treating chronic total occlusions (CTOs), complex bifurcations, heavily calcified lesions, and left main coronary artery disease with large-bore catheters via the radial artery is associated with significantly less access-site bleeding and fewer vascular complications when compared with femoral access, according to the results of the COLOR study.
Researchers say the findings lend further support to performing PCI via the radial artery, this time in the types of complex coronary lesions that have typically been excluded from randomized clinical trials.
“I hope that physicians who are still femoral artery-oriented for complex PCI should move on and use this data to start performing CTOs and other complex procedures with radial access in order to treat these patients safer,” senior investigator Maarten van Leeuwen, MD, PhD (Isala Heart Center, Zwolle, the Netherlands), told TCTMD.
Published: May 21, 2021 By Alex Keown
Biopharma and life sciences companies strengthen their leadership teams and board with these Movers & Shakers.
AavantiBio – Jessie Hanrahan was named chief regulatory officer of AavantiBio. Hanrahan will oversee global regulatory affairs for AavantiBio’s diversified pipeline of gene therapy programs targeting rare diseases with significant unmet medical needs. Most recently, she was Vice President of Regulatory Science at bluebird bio, Inc. Prior to bluebird bio, Hanrahan held positions of increasing responsibility at Genzyme Corp. where she worked across the oncology, multiple sclerosis and rare disease therapeutic areas. Earlier in her career, Hanrahan worked at Boston Scientific Corporation.
How to fix bad sleep habits caused by the pandemic
By: Erica Greenway
and last updated 2021-05-19 22:06:18-04
NORFOLK, Va. - More stress, changes to our schedules and more screen time over the past year have led to less of something we all need - sleep.
A recent survey from Mattress Firm found a lot of people aren t getting the recommended 7-9 hours of sleep a night. As a country, we really need to do better, said Dr. W. Chris Winter, a neurologist and sleep specialist.
While there are a lot of factors, one affecting many of us is electronics.